Abstract: Background. Total pharyngolaryngoesophagectomy and gastric transposition (TPLEGT) for pharyngoesophageal (PE) tumors may require thyroidectomy (with or without removal of the parathyroid glands) to obtain adequate margins around the tumor. As a result, a considerable number of patients may have hypoparathyroidism (HP) develop. The objective of this article is to report our experience with different types of thyroidectomy and to describe the relationship of thyroidectomy to HP in TPLETG. These results are compared with data in the literature.
roidectomy (with or without removal of the parathyroid glands) to obtain adequate margins around the tumor, which may be proximal to or actually within the thyroid gland. As a result, a considerable number of patients may have hypoparathyroidism (HP) develop. The objective of this article is to report our experience with different types of thyroidectomy, to describe the relationship of thyroidectomy to HP in TPLEGT, and also to compare our results with data in the literature.
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PATIENTS AND METHODS
From 1985 to 2001, 41 patients underwent TPLEGT at Unicamp. One patient was excluded from this report because he had a previous thyroidectomy, and the TPLEGT was done for recurrent thyroid cancer involving the cervical esophagus. In the remaining 40 patients, the main index tumors were located in the esophagus (n = 17), hypopharynx (n = 17), and larynx (n = 6). Four of the patients with laryngeal cancer had other primary tumors in the esophagus (synchronous cancers). All patients had persistent rather than recurrent tumors, despite previous surgical procedures (16 patients), radiotherapy (14 patients), or chemotherapy (four patients). Thirtysix patients were men, with a median age of 56.5 years (range, 37 -71 years). In addition to the routine workup, the patients underwent esophagoscopy and esophagography, abdominal ultrasonography, bronchoscopy, and head and neck CT scan or MRI. A tissue diagnosis was obtained in all patients by esophagoscopy or direct laryngoscopy (squamous cell carcinoma). All patients had advanced cTNM or pTNM stages (III or IV), the one exception being a case of esophageal carcinoma (pIIa).
The TPLEGT was routinely done by two teams working together. The neck incision depended on the presence of neck node metastasis, previous tracheostomy, or the need for locoregional flaps. Our preference was for a long collar neck incision whenever possible or for Schobinger's classic neck incision. 18 A midline or Eckert-type 19 incision was used occasionally.
The decision to preserve the gland or to do a partial or total thyroidectomy was based on the preoperative workup and surgical findings at the time of the resection. Postoperative hypoparathyroidism was diagnosed primarily on the basis of symptoms and calcium and phosphorus analysis but not on parathyroid hormone (PTH) levels.
Hypoparathyroidism was treated only in the presence of clinical signs and symptoms of hypocalcemia and was avoided in cases of biochemical hypocalcemia without signs or symptoms. Immediate hypoparathyroidism was treated with 10% calcium gluconate (180 -270 mg, corresponding to 20 -30 mL) diluted in 200 mL of infusion solution and given intravenously in three or four doses over 24 hours. Soon after the beginning of oral or enteral ingestion, the usual treatment of choice for our patients was calcium lactate in powder form, given at doses of 15 to 30 g/day (equivalent to 1 -2 tablespoons). This was combined with 600,000 IU of vitamin D2/week (manipulated calciferol). The occasional use of calcitriol was limited by the patients' financial conditions, but we consider this medication excellent for controlling hypocalcemia.
The patients were followed in the outpatient clinic, with a median follow-up of 18 months (range, 4 -168 months). Locoregional recurrence and distant metastasis were diagnosed on the basis of clinical and radiologic data. Survival was calculated according to the Kaplan -Meier method. Table 2 summarizes the pathology findings. All patients had advanced tumors, and all had epidermoid carcinomas, mostly (75%) grade II. Lymph node metastasis was confirmed histologically in 19 (47.5%) of the cases. Actual invasion of the thyroid was also confirmed in 14 of 37 patients (37.8%) (three thyroid glands were preserved). Invasion of the thyroid was more frequent in retrocricoid tumors, followed by pyriform sinus and laryngeal carcinomas. Invasion of the thyroid by esophageal carcinomas occurred in only two patients (5%). The final pTNM revealed stage III in 16 esophageal carcinomas (94.1%), stage IIa in one esophageal carcinoma (5.9%), stage IV in seven pyriform sinus carcinomas (100%), stage IV in 10 retrocricoid carcinomas (100%), and stage IV in six laryngeal carcinomas (100%). Table 2 shows that 90% of the tumors extended outside the organ of origin. Regardless of the tumor stage, positive margins occurred in only seven patients.
Thyroidectomy and Hypoparathyroidism. Tables 3  and 4 summarize the main focus of this article, namely, thyroidectomy and the occurrence of hypoparathyroidism. In only three patients (7.5%) were the thyroid glands totally preserved (two cases of esophageal and one case of retrocricoid carcinoma). The remaining patients had thyroidectomy that was considered necessary to obtain adequate margins around the primary tumor. Total thyroidectomy (TT) was done in 12 patients (30%), most frequently in retrocricoid (60%) and pyriform sinus (42.8%) carcinoma. Partial thy- §Prevertebral fascia (n = 1), trachea (n = 2), soft parts (n = 1), posterior pharyngeal wall (n = 1), and oropharynx (n = 2).
roidectomy (PT) was done in 25 patients (62.5%), most frequently in esophageal (82.3%), laryngeal (66.6%), and pyriform sinus (57.1%) carcinomas. Only 13 patients (32.5%) did not have immediate or late hypoparathyroidism develop (three cases of preserved thyroid, 10 PT, and none of the TT cases). The location of the primary index tumors in the cases of immediate hypoparathyroidism were the larynx (83.3%), retrocricoid (70%), esophagus (64.7%), and pyriform sinus (57.1%). Five patients (12.5%) had transient HP that was most common in PT (four cases). Three of five cases (60%) of reverted HP involved patients with esophageal carcinomas and partial thyroidectomy. In 22 patients (55%), the HP was permanent, occurring in 91.6% and 44% of cases with TT and PT, respectively, and in none of those with preserved thyroid glands. Permanent HP was more common in laryngeal carcinomas (66.6%), followed by retrocricoid (60%), pyriform sinus (57.1%), and esophageal (47%) carcinomas. The serum calcium levels in HP varied from 5.52 mg/dL to 7.43 mg/dL (median, 6.85 mg/dL).
In summary, TT was done in 12 patients (30%), and 11 (91.6%) had permanent HP. In none of these patients was the parathyroid separated and implanted (fear of a tumor implant). PT (lobectomy and isthmus) was done in 25 patients (62.5%), and permanent HP occurred 11 (44%). In three patients, the thyroid was preserved, and none of these individuals had HP develop. Of the 40 patients, 13 (32.5%) had no HP, five (12.5%) had temporary HP, and 22 (55%) had permanent HP. There was a correlation between the type of thyroidectomy and the occurrence of primary tumors. In 17 patients with esophageal carcinomas, the thyroid was preserved in 11.7%, TT was done in only 5.8%, and PT was done in 82.3%, with permanent HP in eight (47%). In 17 patients with hypopharyngeal sinus carcinoma, TT was done in nine (53%), PT in seven (41%), and there was preservation in one (11.7%); permanent HP occurred in 10 (59%). In six patients with laryngeal carcinoma, TT was done in two (33.3%) and PT in four (66.6%), with permanent HP in four (66.6%).
Additional Data. Although not part of the main objective of this work, additional relevant data published elsewhere 15 -17 are included here to allow a more complete analysis of this study. Locoregional (33 patients; 82.5%) and systemic (22 patients; 55%) complications were prominent in this series of patients. Multiple locoregional and systemic complications occurred frequently in the same patients. The postoperative or hospital mortality was 20% (eight cases). The complications (innominate and carotid rupture, pneumonia, sepsis, arrhythmia, pulmonary embolus) and associated events (infection, malnutrition, previous radiotherapy, tracheal stump complications, chylothorax, and fistula) were identified as the most important causes of death. The follow-up ranged from 4 to 168 months (median, 38 months). Eighteen (45%) of the 40 patients died from disease, five (12.5%) died of other causes, and three (7.5%) were lost to follow-up. Six patients (15%) were long-term survivors (with 168, 164, 126, 94, 67, and 48 months of follow-up, respectively), including four patients with cervical esophageal carcinomas, one with retrocricoid carcinoma, and another with laryngeal carcinoma. The Kaplan -Meier survival curve showed a survival of 35% at 1 year, 25% at 2 years, and 17.6% at 5 years. Figure 1 summarizes the recurrence and distant metastasis in 18 patients who died of disease. Note the low exclusive local recurrence (high frequency of local control) and high incidence of distant metastasis. Metastasis occurred mainly in the lungs (36.3%) and liver (18%).
DISCUSSION
TPLEGT should be indicated only in selected patients, because the procedure involves potentially important complications. However, in some patients, this procedure can offer effective alleviation and occasional cure. The criteria for indicating and excluding patients from this procedure have been discussed. 1 -17 Survival is generally poor, and the prognosis is worsened by the presence of cervical or mediastinal lymph nodes (incidence of 47.5% and 42.5%, respectively), high multicentricity, and a high incidence of distant metastasis. 15 -17 As published before, 17 the mediastinal nodes (including paratracheal and upper paraesophageal nodes) were positive in 0%, 72.7%, and 61.5% of the patients with laryngeal, hypopharyngeal, and esophageal carcinomas, respectively. Hypoparathyroidism is one of the potential locoregional and systemic complications of partial or total thyroidectomy. In our group of patients, we judged that it was safe to preserve the thyroid in only three patients (7.5%), with partial or total thyroidectomy in 62.5% and 30%, respectively. Total thyroidectomy was more frequent in retrocricoid and pyriform sinus carcinomas, and partial thyroidectomy was more frequent in esophageal carcinomas (probably because of the greater distance of the thyroid from the primary tumor). Partial thyroidectomy has been recommended more frequently in recent years, with attempts to prevent HP.
The diagnosis of HP was based on the symptoms and signs of hypocalcemia and the postoperative analysis of serum calcium and phosphorus. Even without PTH assays (as recommended by Isaacson and Snow 20 ), the incidence was high. Although we routinely did a mediastinal dissection, we believe that the extent of the primary tumor was responsible for the high incidence of HP. The advanced stage of the primary tumor prevented us from preserving the parathyroid glands in many of our patients. The impact of TPLEGT on thyroid and parathyroid function has been described 15 but was slightly different in this study. Although in recent years we have tended to preserve at least one lobe of the thyroid when possible, in many patients we feared involved margins. Some authors recommend parathyroid implants, as is done in primary thyroid carcinomas. 20 -22 This has also been suggested for patients who undergo TPLEGT for pharyngoesophageal tumors. 3 However, parathyroid implants were considered inappropriate in most of our patients because of the fear of a tumor implant. This concern was corroborated by the fact that 37.8% of the thyroid glands examined had a pathologic invasion that was more evident in retrocricoid, pyriform sinus, and laryngeal carcinomas. This invasion occurred in only two cases of primary esophageal cancer (5%). The invasion of the thyroid occurred by direct extension of the primary tumor to the posterior aspect of the thyroid in most cases. However, we did have a few cases of venous and lymphatic cancer embolus to the thyroid.
Although there was a high incidence of immediate (67.5%) or permanent HP (55%), the low rate of local recurrence (16.6% vs the median rate of 27% in the literature) may be the best argument against possible criticism (good margins around the tumor) in this study.
The greater frequency of permanent HP in laryngeal primary carcinomas (66.6%) compared with 60% in retrocricoid, 57.1% in pyriform sinus, and 47% in esophageal carcinomas could very well change with the inclusion of more patients in this series. We expected a greater frequency of permanent HP in retrocricoid and pyriform sinus carcinomas.
The occurrence of HP in 91.6% of the cases with TT and in 44% of those with PT indicated that HP is almost certain after TT associated with TPLEGT. Furthermore, PT is no guarantee that HP will not occur. Once HP develops, reversion is infrequent and occurs in only 16.6% and 8.3% of cases with PT and TT, respectively.
The general literature on thyroidectomy 21 -24 shows that the frequency of HP is 0.6% (therefore almost insignificant) after PT for primary benign thyroid disease and about 10% for primary malignant thyroid tumors. According to Thompson and Harness, 23 HP occurs in 5.4% of TT done for malignant primary thyroid carcinomas. In both benign and malignant thyroid disease, good practice dictates the need to identify and preserve the parathyroid. The variation in the frequency of HP reported in primary thyroid carcinomas depends on the diagnostic method used. If the diagnosis is based on the signs/symptoms of hypocalcemia and on the serum levels of calcium and phosphorus, then the incidence of HP is generally low. In contrast, if PTH levels are used, the incidence of HP is greater. 20 Table 5 summarizes the eight available literature reports on hypoparathyroidism and TPLEGT, 1, 6, 8, 10, 11, 13, 14 together with this study. Note that the median percentage of hypoparathyroidism was calculated on the basis of the specific numbers reported and the numbers of the total group. The report by Buchanan et al 2 was left out of the Table 5 , because it deals only with the need for vitamin D replacement therapy.
In the studies indicated in Table 5 , the type of thyroidectomy done was not always indicated. In the eight selected articles cited (and including our own data), HP varied from 20% to 100% (median, 52%) in patients with TT and from 13% to 44% (median, 32.2%) in patients with PT. Considering PT and TT together, the median occurrence of HP was 41.7% (range, 13% to 100%).
Hypoparathyroidism was more frequent in our study than in any of the reports in the literature, except for that of Spiro et al, 11 in which the frequency of HP was 100% for TT. These findings may reflect the aggressive nature of these advanced tumors and the correspondingly aggressive treatment required. Although we argued with low recurrence rate (aggressive primary tumor treatment) in these series to counterpoint criticism, we do have a tendency to preserve parathyroid function (thyroid lobectomy) when feasible, assuming that preservation of at least two parathyroid glands would prevent HP. Of the six long-term survivors in our study, three have had thyroid hormone therapy and treatment with hypocalcemia since thyroidectomy.
CONCLUSION
We conclude that parathyroid function is vulnerable in TPLEGT, primarily because of the radical nature of the disease and treatment. In patients with advanced pharyngoesophageal tumors, TT almost always involves the risk of HP, with little chance of reversing the condition. Even if PT is done, the incidence of HP continues to be significant, with reversal in less than 20% of the patients. Calcium and vitamin D replacement is not a therapeutic problem. In pharyngoesopha- geal tumors, TT is more frequent in retrocricoid, pyriform sinus, and laryngeal carcinomas. TT may be unnecessary in esophageal tumors. At this primary site, thyroid preservation or PT should be considered.
